Japanese encephalitis vaccine - Liaoning ChengDa BiotechnologyAlternative Names: Inactivated vero cell derived vaccine - Liaoning ChengDa Biotechnology; JEVAC
Latest Information Update: 19 Dec 2014
At a glance
- Originator Liaoning ChengDa Biotechnology
- Developer Liaoning ChengDa Biotechnology; Mahidol University
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Japanese encephalitis
Most Recent Events
- 02 Dec 2014 Registered for Japanese encephalitis (In infants, In volunteers, Prevention) in Cambodia (SC)